Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta-analysis.

Christopher J WeatherburnBruce GuthrieTobias DreischulteDaniel R Morales

Published in: British journal of clinical pharmacology (2019)

UK regulatory risk communications were associated with significant changes in targeted prescribing and potential changes in clinical outcomes. Further research is needed to systematically study the impact of regulatory interventions.

Keyphrases

systematic review
primary care
transcription factor
meta analyses
physical activity
cross sectional
randomized controlled trial
emergency department
cancer therapy
risk assessment
human health